 Caitlin Costello
|
| Title(s) | Assistant Clinical Professor of Medicine, Medicine |
|---|
| School | Health Sciences |
|---|
| Phone | 858-822-6600 |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | Harvard University | 2002 | | Cum Laude | | 2004 | | Robert J. Fahey Award for Compassion in Doctoring | | 2006 | | Worth F Bloom Award for High Standard of Excellence and Level of Compassion | | 2010
-
| 2012 | Akliviadis Vasiliadis Fellowship Award for Clinical Research | | 2011 | | American Society of Hematology Abstract Achievement Award | | 2012 | | American Society of Clinical Oncology Travel Award |
Overview Research Interests
As a member of the Division of Blood and Marrow Transplantation, Dr Costello is dedicated to providing excellent care for patients with a variety of hematologic malignancies, with a specific focus in lymphoproliferative disorders and bone marrow transplantation. Dr Costello’s research interests focus particularly on the refinement of the management and treatment of multiple myeloma. She is dedicated to conducting clinical trials with novel agents and treatment strategies to expand the therapeutic options for patients with multiple myeloma. As we enter the age of personalized medicine, Dr. Costello is principally interested in developing treatment strategies that are specific to the most finite genetic and molecular details of each individual patient’s disease.
Education and Training
BA - Biology, Harvard University, Cambridge, MA - 2002
MD - Medicine, Tufts University, School of Medicine, Boston, MA - 2006
Internship/Residency - Internal Medicine, New York Presbyterial/Weill Cornell Medical Center, New York, NY - 2006-2009
Fellowship - Hematology/Oncology, University of California, San Diego, CA - 2009-2012
ORNG Applications Bibliographic
-
Costello C. The future of checkpoint inhibition in multiple myeloma? Lancet Haematol. 2019 Jul 18. PMID: 31327688.
-
Richardson PG, Bensinger WI, Huff CA, Costello CL, Lendvai N, Berdeja JG, Anderson LD, Siegel DS, Lebovic D, Jagannath S, Laubach JP, Stockerl-Goldstein KE, Kwei L, Clow F, Elias L, Salman Z, Graef T, Bilotti E, Vij R. Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. Br J Haematol. 2018 03; 180(6):821-830. PMID: 29435979.
-
Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R. Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2015 Nov; 13(11):1398-435. PMID: 26553768; PMCID: PMC4891187.
|
Concepts Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
|